The Stocks Wall Street Is Watching
The following stocks may be
impacted due to significant news as noted:
Biotech company Genetech
(
DNA |
Quote |
Chart |
News |
PowerRating) announced that it did not pass the Phase III study endpoint for its
breast cancer drug Avastin. The company was also downgraded by Salomon Smith
Barney.
Also in the drug making
business, Shire Pharmaceuticals
(
SHPGY |
Quote |
Chart |
News |
PowerRating) has been upgraded by Morgan
Stanley to “overweight” from “equal-weight” based on increased confidence in
earnings estimates.
Defense contractor Raytheon
(
RTN |
Quote |
Chart |
News |
PowerRating) is reported by the Wall Street Journal to be falling short of its
targets for its business jet Premier 1. The article cites manufacturing problems
and financial issues.
Another drug company Forest
Labs
(
FRX |
Quote |
Chart |
News |
PowerRating) has announced a positive trial for its Alzheimer’s
treatment. The company said a significant benefit was observed, and full results
will be released at the end of the year.
Â